RT Journal Article SR Electronic T1 PREOPERATIVE SERUM ALBUMIN LEVEL AS A PREDICTOR OF MORTALITY AND MORBIDITY AFTER VALVE REPLACEMENT SURGERY JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2020.10.13.20206409 DO 10.1101/2020.10.13.20206409 A1 Md. Noor-E-Elahi Mozumder A1 Md. Mostafizur Rahman A1 Md. Rezwanul Hoque A1 Muhammad Nasif Imtiaz A1 Abu Jafar Md. Tareq Morshed A1 Md. Zanzibul Tareq A1 Md. Nahedul Morshed YR 2020 UL http://medrxiv.org/content/early/2020/10/15/2020.10.13.20206409.abstract AB Background Serum albumin has a close correlation with degree of malnutrition which is associated with poor outcome and quality of life after cardiac surgery. Hypoalbuminemia is associated with increased wound infection, prolonged hospital stay and death after major surgery. Hence, preoperative serum albumin level can be utilized to upgrade risk models which will further benefit the cardiac surgical patients without extra financial burden. Objective of this study was to evaluate the role of serum albumin as a predictor of morbidity and mortality after valve replacement surgery.Methods This comparative cross-sectional study was carried out at the department of cardiac surgery in BSMMU. The study population was 50, with two groups having 25 patients each. Grouping of patients were done with respect to a preset cut off value for serum albumin. The period of study was from August, 2018 to February, 2020 and purposive sampling method was applied for this study. Data was collected by using a standardized semi-structured questionnaire and face to face interview.Results By demographic characteristics, mean age was significantly higher in group B (49.96±8.69 years) than in group A (41.60±11.16 years) (p=0.005). Mean BMI was lower in group B (20.88±3.71 kg/m2) than in group A (22.26±1.67 kg/m2), which was found statistically significant (p=0.006). In terms of postoperative outcome, total chest drain collection was significantly higher in group B (968.80±183.49 ml) than in group A (816.00±113.40 ml), (p=0.001). Duration of ICU stay were significantly longer in group B (4.60±0.76 days) than in group A (3.92±0.86 days) (p=0.005). Similarly, duration of hospital stay was significantly longer in group B (9.88±1.56 days) than in group A (8.64±0.81 days) (p=0.001). Overall morbidity was significantly higher in group B (48%) than in group A (20%) (p<0.05). Mortality rate was higher in group B (12%) than in group A (4%), but that was not found statistically significant (p>0.05). Pearson co-efficient correlation test showed strong inverse relationship of serum albumin with total chest drain, ICU stay and hospital stay following valve replacement surgery (r= −0.473, r= −0.448 & r= −0.487 respectively), which was most significant than age and BMI (p≤0.001). Multivariate logistic regression analysis was done to assess the predictive value of serum albumin level, age and BMI, where preoperative serum albumin level was found to be the most valuable predictor of postoperative morbidity after valve replacement surgery (B= −2.251, OR 0.105, 95% CI 0.011-0.986, p<0.05).Conclusion This study demonstrated that preoperative low serum albumin level is associated with increased morbidity and mortality after valve replacement surgery. Hence, preoperative serum albumin level can be used as a reliable predictor of postoperative outcome following valve replacement surgery.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was not funded.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Institutional review board of Bangabandhu Sheikh Mujib Medical University has approved this research.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesCorresponding author has all data available with himself